Skip to main content
. 2021 Nov 2;10(2):241–254. doi: 10.1002/iid3.557

Figure 2.

Figure 2

The prognosis analysis of myosin light chain 9 (MYL9) gene expression in PrognoScan and Kaplan–Meier plotter datasets for different tumors. The effects of MYL9 expression on prognosis among various types of cancers in the PrognoScan dataset (A–L) and Kaplan–Meier database (M–T). DFS, disease‐free survival; DMFS, distant metastasis‐free survival; DSS, disease‐specific survival; FP, first progression; OS, overall survival; PFS: progression‐free survival; PPS: postprogression survival; RFS, relapse‐free survival